BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3579600)

  • 41. Plasma metallothionein antibody, urinary cadmium, and renal dysfunction in a Chinese type 2 diabetic population.
    Chen L; Lei L; Jin T; Nordberg M; Nordberg GF
    Diabetes Care; 2006 Dec; 29(12):2682-7. PubMed ID: 17130205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of cadmium-metallothionein pretreatment on tolerance of rat kidney cortical cells to cadmium toxicity in vitro and in vivo.
    Jin T; Nordberg GF; Nordberg M
    Pharmacol Toxicol; 1987 May; 60(5):345-9. PubMed ID: 3615344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary excretion of metallothionein-I and its degradation product in rats treated with cadmium, copper, zinc or mercury.
    Sato M; Nagai Y; Bremner I
    Toxicology; 1989 May; 56(1):23-33. PubMed ID: 2728004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metallothionein excretion in urine upon cadmium exposure: its relationship with liver and kidney cadmium.
    Tohyama C; Shaikh ZA; Ellis KJ; Cohn SH
    Toxicology; 1981; 22(3):181-91. PubMed ID: 7340007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urinary proteoglycans after cadmium exposure.
    Savolainen H
    Res Commun Chem Pathol Pharmacol; 1993 Nov; 82(2):241-4. PubMed ID: 8303093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dose-response relationship for renal dysfunction in a population environmentally exposed to cadmium.
    Nogawa K; Kido T; Shaikh ZA
    IARC Sci Publ; 1992; (118):311-8. PubMed ID: 1303957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of cadmium and lead exposure on urinary N-acetyl-beta-D-glucosaminidase, beta 2-microglobulin and metallothionein of workers.
    Kawada T; Tohyama C; Suzuki S
    Asia Pac J Public Health; 1995; 8(2):91-4. PubMed ID: 9037804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Markers of cadmium exposure in workers in a cadmium pigment factory after changes in the exposure conditions.
    Kawasaki T; Kono K; Dote T; Usuda K; Shimizu H; Dote E
    Toxicol Ind Health; 2004 Jun; 20(1-5):51-6. PubMed ID: 15807408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of changes in dietary zinc, copper and selenium supply and of endotoxin administration on metallothionein I concentrations in blood cells and urine in the rat.
    Bremner I; Morrison JN; Wood AM; Arthur JR
    J Nutr; 1987 Sep; 117(9):1595-602. PubMed ID: 3309208
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A polymorphism in metallothionein 1A (MT1A) is associated with cadmium-related excretion of urinary beta 2-microglobulin.
    Lei L; Chang X; Rentschler G; Tian L; Zhu G; Chen X; Jin T; Broberg K
    Toxicol Appl Pharmacol; 2012 Dec; 265(3):373-9. PubMed ID: 22995156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of renal function of workers simultaneously exposed to inorganic lead and cadmium.
    Buchet JP; Roels H; Bernard A; Lauwerys R
    J Occup Med; 1981 May; 23(5):348-52. PubMed ID: 7241248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary levels of metallothioneins and metals in subjects from a semiindustrialized area in Tarragona Province of Spain.
    Folch J; Ortega A; Cabré M; Paternáin JL
    Biol Trace Elem Res; 1998 Aug; 63(2):113-21. PubMed ID: 9823437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Toxicokinetics and biochemistry of cadmium with special emphasis on the role of metallothionein.
    Jin T; Lu J; Nordberg M
    Neurotoxicology; 1998; 19(4-5):529-35. PubMed ID: 9745907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biological indicators of cadmium exposure and toxicity.
    Shaikh ZA; Smith LM
    Experientia Suppl; 1986; 50():124-30. PubMed ID: 3525214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of amphipathic dithiocarbamates in intracellular cadmium mobilization and in modulation of hepatic and renal metallothionein in cadmium pre-exposed rat.
    Tandon SK; Prasad S; Singh S; Agarwal DK
    Chem Biol Interact; 1998 Jul; 114(3):161-75. PubMed ID: 9839629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of biological and environmental factors on metallothionein concentration in the blood.
    Kowalska K; Bizoń A; Zalewska M; Milnerowicz H
    J Trace Elem Med Biol; 2015 Jan; 29():99-103. PubMed ID: 24912972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Validity of some urinary tests considered singly or in combination in the study of renal effects of cadmium].
    Apostoli P; Brandi F; Toffoletto F; Alessio L
    Med Lav; 1990; 81(2):147-56. PubMed ID: 2250610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alpha 1-microglobulin in urine as an indicator of renal tubular damage caused by environmental cadmium exposure.
    Nogawa K; Kido T; Yamada Y; Tsuritani I; Honda R; Ishizaki M; Terahata K
    Toxicol Lett; 1984 Jul; 22(1):63-8. PubMed ID: 6205474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolism of 35S-labelled copper-, zinc-and cadmium-thionein in the rat.
    Bremner I; Hoekstra WG; Davies NT; Young BW
    Chem Biol Interact; 1978 Dec; 23(3):355-67. PubMed ID: 719815
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kidney dysfunction and cadmium exposure--factors influencing dose-response relationships.
    Nordberg G; Jin T; Wu X; Lu J; Chen L; Liang Y; Lei L; Hong F; Bergdahl IA; Nordberg M
    J Trace Elem Med Biol; 2012 Jun; 26(2-3):197-200. PubMed ID: 22565016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.